06.27.2022 - By Pocket Psychiatry: A Carlat Podcast
Atomoxetine (Strattera) was approved by the FDA for ADHD treatment in 2002, but how effective is it and where does it stack up against other treatments?CME: Take the CME Post-Test for this episode (https://www.thecarlatreport.com/carlat-psychiatry-podcast-cme-subscription/)Published On: 06/27/2022Duration: 13 minutes, 38 secondsReferenced Article: “Atomoxetine for Children and Adolescents: An Update (https://www.thecarlatreport.com/the-carlat-child-psychiatry-report/atomoxetine-for-children-and-adolescents-an-update/),” The Carlat Child Psychiatry Report, January/February/March 2022Joshua Feder, MD, and Mara Goverman, LCSW, have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.